Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination ...

As Chair of the Scientific Advisory Committee, Dr. Lewis-Hall will provide leadership in scientific, clinical, and regulatory governance across Helus' portfolio, advising on discovery opportunities, ...

For the 20 years Blonski took Depo-Provera, she thought it was safe. Her lawsuit claims that had she known of the dangers ...

A remote mountain town in Canada has been shaken by the country’s deadliest school shooting in decades, when an armed assailant killed at least eight people. Police found six people dead and dozens ...

Pfizer recently reported earnings, which weren't terribly impressive. Concerns about its future growth have weighed on its valuation in recent years. Impairment charges have impacted its bottom line, ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer made ...

As Priovant works toward approval of potential blockbuster brepocitinib as a treatment for dermatomyositis, the North Carolina biotech has presented promising results for the TYK2/JAK1 inhibitor in ...

Exclusive interview with Pfizer CEO Albert Bourla as the company files for emergency use authorization for its COVID-19 vaccine from the FDA. Pfizer is the first ...

Pfizer Canada's investment of $900,000 supports projects nationwide that help improve the lives and care of Canadians living with lung, colorectal, prostate or bladder cancer. KIRKLAND, QC, Feb. 4, ...

A Saab Gripen E-series fighter aircraft is seen in the sky over the airport of Linkoping, Sweden, as it is shown to the Ukrainian president during his visit on Oct. 22, 2025. (Jonathan Nackstrand/AFP ...